Michael Bookman serves as Executive at Immuneering Corp, where they oversee executive responsibilities. Since joining the company, Michael Bookman has executed 5 insider transactions totaling $32.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 3, 2026 involved receiving (via award) 176,000 shares valued at $0.
Michael Bookman currently holds 176,000 shares of Immuneering Corp (IMRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Bookman has been a net buyer of IMRX stock. They have purchased $32.9K and sold $0 worth of shares.
Michael Bookman's most recent insider trade was on Feb 3, 2026, when they sold 176,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.83 |
| Discretionary |
| Mar 15, 2024 | IMRX | $2.3K | Award | 1,448 | $1.62 | Discretionary |
| May 17, 2022 | IMRX | $4.9K | Purchase | 1,000 | $4.88 | Discretionary |
| Aug 3, 2021 | IMRX | $21.0K | Purchase | 1,402 | $15.00 | Discretionary |